Skip to contentM
Mesa Laboratories Inc
M
MLABMesa Laboratories Inc Q1 2020 · 10-Q
Revenue$26.29M$26.29M+4.6% vs Q1 2019 Net income—
EPS Diluted$1.13$1.13+6.6% vs Q1 2019 Gross Profit$16,139,000+6.9% Operating Income$5,392,000+13.2% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
Operating Cash Flow$724,000−88.9% Free Cash Flowderived$498,000— Margins · derivedGross margin61.4%+1.4 pt vs Q1 2019
Operating margin20.5%+1.6 pt vs Q1 2019
ended Jun 30, 2019 · filed Jul 30, 2019 · 30 d after period end